California Public Employees Retirement System Has $366.35 Million Position in CME Group Inc. $CME

California Public Employees Retirement System trimmed its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 16.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,329,187 shares of the financial services provider’s stock after selling 252,850 shares during the quarter. California Public Employees Retirement System owned approximately 0.37% of CME Group worth $366,351,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Jessup Wealth Management Inc lifted its stake in shares of CME Group by 0.5% in the 2nd quarter. Jessup Wealth Management Inc now owns 7,969 shares of the financial services provider’s stock valued at $2,197,000 after acquiring an additional 36 shares during the last quarter. First Horizon Advisors Inc. raised its position in CME Group by 0.7% in the second quarter. First Horizon Advisors Inc. now owns 5,269 shares of the financial services provider’s stock valued at $1,453,000 after purchasing an additional 36 shares during the last quarter. Great Lakes Advisors LLC boosted its stake in shares of CME Group by 2.3% during the first quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider’s stock valued at $441,000 after purchasing an additional 37 shares in the last quarter. MBM Wealth Consultants LLC grew its holdings in shares of CME Group by 2.7% during the second quarter. MBM Wealth Consultants LLC now owns 1,422 shares of the financial services provider’s stock worth $392,000 after purchasing an additional 37 shares during the last quarter. Finally, Beaumont Financial Advisors LLC grew its holdings in shares of CME Group by 2.0% during the second quarter. Beaumont Financial Advisors LLC now owns 1,952 shares of the financial services provider’s stock worth $538,000 after purchasing an additional 38 shares during the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Performance

Shares of CME Group stock opened at $270.87 on Friday. The business has a 50-day moving average price of $271.57 and a two-hundred day moving average price of $272.76. CME Group Inc. has a 1-year low of $224.62 and a 1-year high of $290.79. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The company has a market cap of $97.68 billion, a P/E ratio of 26.25, a PEG ratio of 4.22 and a beta of 0.28.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The company had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.56 billion. During the same period in the previous year, the business earned $2.68 EPS. The firm’s revenue was down 3.0% compared to the same quarter last year. As a group, analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th will be paid a $1.25 dividend. The ex-dividend date is Friday, December 12th. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. CME Group’s payout ratio is currently 48.45%.

Insider Activity at CME Group

In other news, Director William R. Shepard bought 262 shares of the firm’s stock in a transaction that occurred on Thursday, September 25th. The stock was acquired at an average cost of $265.19 per share, with a total value of $69,479.78. Following the transaction, the director directly owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. This represents a 0.10% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the transaction, the general counsel directly owned 7,851 shares in the company, valued at $2,056,962. The trade was a 4.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders have sold 2,147 shares of company stock worth $562,079. 0.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

Several research firms recently commented on CME. The Goldman Sachs Group cut their target price on shares of CME Group from $264.00 to $263.00 and set a “sell” rating on the stock in a research report on Thursday. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of CME Group from $300.00 to $310.00 and gave the stock a “buy” rating in a research note on Friday, November 14th. Citigroup raised CME Group from a “neutral” rating to a “buy” rating and raised their target price for the stock from $275.00 to $300.00 in a research report on Thursday, September 25th. Rothschild & Co Redburn lifted their target price on CME Group from $297.00 to $300.00 and gave the stock a “neutral” rating in a report on Thursday, November 6th. Finally, Argus reduced their price target on CME Group from $308.00 to $295.00 in a research report on Friday, October 31st. Eight investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $289.18.

Read Our Latest Analysis on CME Group

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.